The Japan Fair Trade Commission has issued an order to pay a total surcharge of 420 million yen to three major drug wholesalers convicted in a bid-rigging case involving drug bids.
The three major pharmaceutical wholesalers, Alfresa, Toho Pharmaceutical, and Suzuken, have pre-assigned contractors for drug bids at 57 hospitals operated by the Japan Community Health Care Organization. In June last year, they were convicted of a fine of 250 million yen by the Tokyo District Court for violating the Antimonopoly Act for having a collusion.
The Fair Trade Commission, which investigated this bid rigging, held a press conference on the 30th and issued an order to pay a surcharge of about 175 million yen to Alfresa, 161 million yen to Toho Pharmaceutical, and 86 million yen to Suzuken. Announced that it was done.
In addition, we have issued cease and desist orders to the three companies to take necessary measures to eliminate violations and prevent recurrence.
This bid rigging was held by four major companies, including three, but the criminal accusation of "Mediceo", which first reported fraud to the Fair Trade Commission, was postponed and was not subject to this disposition. did.
Alfresa, Toho Pharmaceutical, and Suzuken each commented that they would "thoroughly prevent recurrence."